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Abstract
Background: SIRT2 belongs to a highly conserved family of NAD+-dependent deacylases, consisting of seven members
(SIRT1–SIRT7), which vary in subcellular localizations and have substrates ranging from histones to transcription factors and
enzymes. Recently SIRT2 was revealed to play an important role in inflammation, directly binding, deacetylating, and
inhibiting the p65 subunit of NF-kB.
Methods: A Sirt2 deficient mouse line (Sirt22/2) was generated by deleting exons 5–7, encoding part of the SIRT2
deacetylase domain, by homologous recombination. Age- and sex-matched Sirt22/2 and Sirt2+/+ littermate mice were
subjected to dextran sulfate sodium (DSS)-induced colitis and analyzed for colitis susceptibility.
Results: Sirt22/2 mice displayed more severe clinical and histological manifestations after DSS colitis compared to wild type
littermates. Notably, under basal condition, Sirt2 deficiency does not affect the basal phenotype and intestinal morphology
Sirt2 deficiency, however, affects macrophage polarization, creating a pro-inflammatory milieu in the immune cells
compartment.
Conclusion: These data confirm a protective role for SIRT2 against the development of inflammatory processes, pointing
out a potential role for this sirtuin as a suppressor of colitis. In fact, SIRT2 deletion promotes inflammatory responses by
increasing NF-kB acetylation and by reducing the M2-associated anti-inflammatory pathway. Finally, we speculate that the
activation of SIRT2 may be a potential approach for the treatment of inflammatory bowel disease.
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Introduction
Intestinal bowel disease (IBD) is a chronically recurring
inflammatory disorder arising from genetic predispositions and/
or environmental or immunological modifying factors [1,2] that
negatively affect the interaction between the commensal micro-
flora and the intestinal mucosa [3]. The two most common forms
of IBD are Crohn’s disease (CD) and ulcerative colitis (UC). These
diseases often result in morbidity due to a high incidence of
diarrhea, abdominal pain, rectal bleeding and malnutrition [1].
Despite significant progresses, our understanding of the inflam-
matory regulators that contribute to the pathogenesis of IBD is still
limited.
Recently, SIRT2, an NAD+-dependent sirtuin deacetylase, was
revealed to play an important role in inflammation [4,5,6,7].
SIRT2 belongs to a highly conserved family of NAD+-dependent
enzymes, consisting of seven members (SIRT1–SIRT7), which
vary in subcellular localizations and have substrates ranging from
histones to transcription factors and enzymes [8,9]. SIRT2 is
primarily a cytosolic protein, but can shuttle into the nucleus
[10,11], thus explaining its ability to deacetylate both cytosolic
(e.g. a-tubulin) [11] and nuclear (e.g. histones) [10] substrates. In
the context of inflammation, SIRT2 was shown to directly bind
and deacetylate the p65 subunit of NF-kB [4], a major
transcriptional regulator of the inflammatory response [12].
Accordingly, p65 is hyperacetylated in Sirt22/2 mouse embryonic
fibroblasts following TNFa stimulation, resulting in NF-kB-
dependent gene activation and increased apoptosis [4]. Further-
more, in vivo experiments show that SIRT2 is an important
inhibitor of microglia-mediated inflammation in the brain [5], and
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of inflammatory factors leading to arthritis [6]. These discoveries
led to the use of SIRT2 as an anti-inflammatory therapeutic
target, as was recently demonstrated by using a permeative
protein, Pep-1, to transduce SIRT2 into epithelial cells [7].
Transduction of cells with Pep-1-SIRT2 reduced inflammation by
attenuating the expression of cytokines and activation of both NF-
kB and mitogen activated protein kinases (MAPKs). These recent
findings prompted us to examine the potential contribution of
SIRT2 in the development of IBD.
In the present study, we demonstrate that SIRT2 is critical for
modulating macrophage polarization and intestinal permeability,
thereby inhibiting the development of colitis. More specifically,
SIRT2 knockout (Sirt22/2) mice developed more severe colitis
when exposed to the chemical colitis inducer, dextran sulfate
sodium (DSS) [13]. This phenotype appears to be consequent to a
hyper-activated immune cell compartment with secondary chang-
es in the intestinal epithelium. In fact, the intestinal histological
appearance and the expression of genes involved in intestinal
permeability are similar between untreated Sirt22/2 and wild type
(Sirt2+/+) mice. However, Sirt22/2 bone marrow-derived macro-
phages (BMDMs) show an activation of inflammatory genes, along
with the hyperacetylation of the NF-kB subunit p65, confirming a
pro-inflammatory state in untreated mice. Therefore, since sirtuins
are considered druggable enzymes, our results suggest that




The generation of Sirt2 floxed (Sirt2L2/L2) mice has been
described before [14]. Sirt2L2/+ mice (heterozygote conditional
animals that have the conditional allele with Lox sites) were
selected and intercrossed with CMV-Cre mice to delete the Sirt2
gene in the male germline. Offspring with a deleted allele (Sirt2L2/+
mice) were then mated to C57BL/6J mice in order to remove the
Cre-transgene. The resulting Sirt2L2/+ offspring without the Cre
transgene were then backcrossed for 10 generations onto commer-
cial C57BL/6J mice purchased from the Jackson Laboratory to
generate heterozygous Sirt2L2/+ mice, from now on simply termed
Sirt22/+ mice. Breedings were only performed with such congenic
heterozygous Sirt22/+ mice to generate the cohorts of male Sirt22/2
and Sirt2+/+ littermates used for the in vivo studies. Animal
experiments were done in accordance with institutional and Swiss
guidelines and approved by the authorities of the Canton of Vaud.
Moreover, all animal experiments were conformed to the Swiss
Animal Welfare legislation and reviewed by the State Ethical Board
of the Canton de Vaud (Animal Welfare Act 2005; Project License
Nu 2463.1 licensed to Prof. Johan Auwerx). Mice were euthanatized
using a brief exposure to CO2. This method leads to quick and
painless asphyxiation of mice. All the experiments were carried out
from January 2013 to May 2014.
Antibodies
FACS analysis of mesenteric lymph node cells: CD4-APC
(eBioscience, clone GK1.5), TCRb-PE (eBioscience, clone H57-
597), CD69-biotin (eBioscience, clone H1.2F3), Streptavidin-
FITC, (eBioscience). Immunohystochemistry: F4/80 (AbD Ser-
otec; MCA497). Western blot: SIRT2 (H-95, SantaCruz sc-
20966), Acetyl-NF-kB (Acetyl-K310, Abcam, ab19870), phospho-
IKba (ser32/36, Cell Signaling 9246), IKba (L35A5, Cell
Signaling 4814), Hsp90 (BD Transduction Laboratories, 610418).
DSS-induced colitis
DSS-induced colitis was induced as previously described [15]
using 2.5% dextran sulfate sodium (36–50 KDa, MP Biomedicals)
solution in water. Daily changes in body weight were assessed.
Rectal bleeding was scored on a scale from 0 to 5, indicating no (0)
or highly severe (5) rectal bleeding. Colons were snap-frozen or
fixed with 4% Forma-Fixx (Thermo scientific) and embedded in
paraffin. In vivo intestinal permeability was examined in mice as
was previously described [16].
Mesenteric lymph nodes isolation and FACS analysis
Mesenteric lymph nodes (MLNs) were dissected from DSS-
treated mice and a single cell suspension was obtained by passing
the MLNs through a 40 mm filter. After counting, the cell
suspension was incubated in HBSS containing 25 mM HEPES
and the primary antibody. Incubation with anti-biotin antibody
was performed when indicated. FACS analysis was performed on
CyAn ADPS analyzers (Beckman Coulter).
Cytokine measurement
Blood was collected from mice at sacrifice and plasma EDTA
was obtained after centrifugation at 3000 rpm for 10 minutes at
4uC. Cytokine concentration in the plasma was measured by using
the Mouse Proinflammatory Panel 1 kit (Meso Scale Diagnostics)
following manufacturer’s instructions.
mRNA extraction and RT-qPCR analysis
RNA was isolated from colon or bone marrow-derived
macrophages using the TriPure reagent (Roche) according with
manufacturer’s instructions. cDNA was generated from 1 mg of
total RNA using QuantiTect Reverse Transcription Kit (Qiagen).
qRT-PCR was carried out using LightCycler 480 SYBR Green I
Master Mix (Roche) and analyzed through DDCT calculation.
Values were normalized to Cyclophilin expression. Primers: Il6
(Fw GAGGATACCACTCCCAACAGACC; Rv AAGTGCAT-
CATCGTTGTTCATACA); Il1b (Fw CAACCAACAAGTGA-
TATTCTCCATG; Rv GATCCACACTCTCCAGCTGCA);
Tnfa (Fw GGGACAGTGACCTGGACTGT; Rv AGGCTGTG-
CATTGCACCTCA); Occludin (Fw AGCCTCGGTACAGCA-
GCAAT; Rv CCTTCGTGGGAGCCCTTT); Claudin-1 (Fw
CATAGGCACGGACTTCTGGTA; Rv CCAGGCGATTT-
TATTCGAGTCAC); Zo1 (Fw GACTCCAGACAACATCCC-
GAA; Rv AACGCTGGAAATAACCTCGTTC); Jam-A (Fw
ACCCTCCCTCCTTTCCTTAC; Rv CTAGGACTCTTGCC-
CAATCC); Mcp-1 (Fw AGGTCCCTGTCATGCTTCTG; Rv
GCTGCTGGTGATCCTCTTGT); Gata3 (Fw CTCGGCCAT-
TCGTACATGGAA; Rv GGATACCTCTGCACCGTAGC);
Arg1 (Fw GCAGAGGTCCAGAAGAATGGAA; Rv GCGTGG-
CCAGAGATGCTT); CD11c (Fw ACGTCAGTACAAGGA-
GATGTTGGA; Rv ATCCTATTGCAGAATGCTTCTT-
TACC); Il4R (Fw TCTGCATCCCGTTGTTTTGC; Rv GCA-
CCTGTGCATCCTGAATG); Il10 (Fw CATGGCCCA-
GAAATCAAGGA; Rv GGAGAAATCGATGACAGCGC), Cy-
clophilin (Fw CAGGGGAGATGGCACAGGAG; Rv CGGCT-
GTCTGTCTTGGTGCTCTCC).
Intestine isolation, immunohistochemistry, and scoring
Colon was excised and collected from the cadavers, carefully slit
opened longitudinally along the antimesenteric side. Feces were
removed from the lumen and each segment was rolled on a
wooden stick with the serosal side adhering to it. The Swiss rolls
were then placed in 4% Forma-Fixx for 24 hours. Paraffin
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embedding was then performed. 5 mm thick sections were cut from
paraffin blocks. Slides were respectively stained with hematoxylin/
eosin for morphologic analysis of the tissue and with F4/80 for
quantification of macrophages. The number of F4/80 positive
cells in the tunica mucosa was scored as count of number of
positive cells with clear morphology in 6 random fields at 4006
magnification. Areas presenting artifacts were excluded from the
analysis. The histopathological evaluation of the specimens was
performed by a European board certified veterinary pathologist in
a blinded fashion according with the following scoring: Erosion/
ulceration: 5–10% (1); 20–30% (2); 40–50% (3); 60–70 (4); 80–90
(5); 100% (6). Inflammation severity: minimal (1); mild (2);
moderate (3); severe (4); very severe (5). Mural involvement:
mucosa (1); submucosa (2); tunica muscularis (3); serosa (transmu-
ral) (4); transmural reaching mesentery (steatitis) (5). Damage
distribution: ,25% (1); 26–50% (2); 51–75% (3); .75% (4).
Bone marrow-derived macrophages (BMDM) isolation
and stimulation
Bone marrow derived macrophages (BMDMs) were isolated
from femurs and tibias of sibling 8- to 10-week-old male Sirt2+/+
and Sirt22/2 sibling mice. Cells were plated on bacteriological
plastic plates in macrophage growth medium consisting of RPMI-
1640 (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 16 non
essential amino acids (Invitrogen), 5 mM penicillin/streptomycin
(Invitrogen), 10% heat-inactivated foetal bovine serum (GE
Healthcare) supplemented with 10% L-cell-conditioned medium
as a source of CSF-1. After one day, non-adherent cells were
collected and seeded at 105 cells/ml in bacteriological plates and
grown for 7 days. Differentiated BMDMs were stimulated with
LPS (10 ng/ml) or with IL-4 (10 nM) for 6 and 24 h, respectively.
Statistical Analyses
The comparison of different groups was carried out using a
Student’s t-test and a two-way analysis of variance (ANOVA), and
differences with a P,0.05 were considered statistically significant
(*P,0.05, ** P,0.01, *** P,0.001).
Results
Sirt22/2 mice have normal colon morphology
To study the possible involvement of SIRT2 in the pathogenesis
of colitis, we first generated a Sirt2 deficient mouse line (Sirt22/2)
by targeting part of the SIRT2 deacetylase domain (exons 5–7), by
homologous recombination in ES cells (Figure 1A). In silico
translation of this Sirt2-deletion product, results in short incom-
plete peptides when examining all potential reading frames. As a
result, no SIRT2 protein was detected in any of the tissues
analyzed from Sirt22/2 mice (Figure 1B). The offspring of
heterozygous Sirt2+/2 breeders were born under normal Mende-
lian (+/+ : +/2 : 2/2= 24.7% : 48.1% : 27.2%) and sex ratios
(male : female = 48.1% : 51.9%) (Figure 1C), with no differences
observed in body weight or body composition between Sirt22/2
and Sirt2+/+ mice (Figure 1D). Colon morphology of Sirt2+/+ and
Sirt22/2 mice was then examined under basal conditions. The
morphological analysis of the colons did not reveal any qualitative
and/or quantitative differences, in terms of crypts depth, epithelial
cell differentiation, wall thickness or density of leukocytes in the
colon between the two genotypes (Figure 2A). Moreover, the
immunohistochemical quantification of macrophages (F4/80+
cells) within the tunica mucosa of the colon revealed no differences
between the two groups (Figure 2B). Thus, Sirt2 deficiency does
not appear to affect the basal phenotype and intestinal morphol-
ogy of Sirt22/2 mice when compared with their wild type
counterparts.
Sirt2 deficiency increases the severity of DSS-induced
colitis
To test whether Sirt2 deficiency contributes to the development
of colitis, we exposed Sirt2+/+ and Sirt22/2 mice to DSS to
chemically induce intestinal inflammation [17]. Sirt2-deficiency
significantly accelerated body weight loss (Figure 3A) and
increased the rectal bleeding score (Figure 3B) after DSS
treatment. Furthermore, plasma levels of FITC-conjugated
dextran were markedly increased in Sirt22/2 mice (Figure 3C),
indicating increased intestinal epithelial permeability. The total
histological score, accounting for the overall severity of intestinal
inflammation, was significantly higher in the colons of Sirt22/2
mice (Figure 3D). In particular, Sirt22/2 mice showed a three-fold
increase in the extent of epithelial cell loss (ranging from erosion to
ulceration) compared to Sirt2+/+ littermates (Figure 3E). The
inflammation severity, evaluated by the leukocytic infiltration
density, was also significantly increased in Sirt22/2 mice, with a
strong tendency to form follicular aggregates within the mucosal
layer (Figure 3F). Finally, more frequent transmural infiltration of
inflammatory cells was observed in the tunica serosa (peritonitis)
and even in the mesenteric fat tissue (steatitis) of Sirt22/2 mice
(Figure 3G), while mural extension occurred less in Sirt2+/+ mice.
The overall distribution of intestinal damage was often multifocal
for both groups, although, in Sirt22/2 mice the percentage of
affected tissue was significantly higher (Figure 3H). Thus, DSS
resulted in a heavily exacerbated form of colitis in the Sirt22/2
mice when compared to the Sirt2+/+ animals.
Furthermore, the cell composition of mesenteric lymph nodes,
as determined by FACS analysis, was distinct between the two
genotypes. Although no difference was observed in the total
amount of CD4+ T lymphocytes, Sirt22/2 mice had an increased
proportion of activated lymphocytes (CD4+/CD69+) compared to
the control mice (Figure 4A–B), consistent with an enhanced
inflammatory response.
Taken together these data show that SIRT2 plays an important
role in protecting from DSS-induced colitis and that its deficiency
exacerbates the clinical and pathological severity of disease
progression.
Sirt2 deficient mice show increased levels of pro-
inflammatory cytokines
Pro-inflammatory cytokines such as TNFa, IL1b, and IL6 play
pivotal roles in the pathogenesis of colitis [18]. Since colitis is a
systemic inflammatory disease, we measured cytokine levels in the
plasma of Sirt2+/+ and Sirt22/2 mice, during basal conditions and
after DSS treatment. Under normal conditions both genotypes of
mice showed similar levels of plasma cytokines (Figure 5A–C).
However, after DSS treatment, plasma levels of TNFa and IL1b
were more elevated in Sirt22/2 mice, compared to the Sirt2+/+
animals (Figure 5A–B), whereas IL6 levels, although increased by
DSS treatment, remained indistinguishable between the two
genotypes (Figure 5C). Unlike the plasma cytokine levels, the
colon mRNA levels of Tnfa and Il1b were already modestly
higher in Sirt22/2 mice in basal conditions (Figure 5D–E).
Following DSS, an induction in the expression of the mRNAs
coding for these cytokines occurred in both genotypes; however,
only the induction of Tnfa transcript was significantly different in
Sirt22/2 from Sirt2+/+ mice (Figure 5D). Notably, Il6 mRNA
levels were again indistinguishable between both genotypes, both
before and after DSS (Figure 5F).
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Together with inflammatory mediators, tight junctions (TJs),
which control epithelial paracellular permeability, have a funda-
mental role in IBD development and progression. Patients with
IBD have both disrupted intestinal epithelial barrier function and
altered expression of TJ proteins [19,20]. Thus, we analyzed the
transcript levels of some principal TJ proteins, including Occludin
(Ocln), Claudin-1 (Cldn1) and Zona Occludens-1 (Zo1) [21].
Under basal conditions no differences in the expression of the
aforementioned genes were observed between Sirt2+/+ and Sirt22/
2 mice, confirming that Sirt2 deficiency in colon tissue does not
directly affect intestinal physiology (see also Figure 2). However,
upon the DSS challenge a significant decrease in the transcripts of
these TJ proteins was observed in Sirt22/2 mice (Figures 5G–H).
Interestingly, only Cldn1 expression decreased in both genotypes
following DSS treatment (Figure 5H), yet the percent reduction
was significantly higher in Sirt22/2 mice. These results clearly
indicate that Sirt2 deficiency promotes inflammatory processes
and intestinal permeability during the development DSS-depen-
dent colitis.
Sirt2 deficiency alters immune cell activation following a
DSS-challenge
Considering that SIRT2 deficiency does not alter the homeo-
stasis of the intestinal epithelium under normal conditions, we
hypothesized that the contribution of the immune cell compart-
ment may be the primary event causing more severe DSS-induced
colitis in the Sirt22/2 animals. Therefore we examined the
immune status of bone marrow-derived macrophages (BMDMs)
from Sirt2+/+ and Sirt22/2 mice. Under basal conditions, gene
expression analysis in Sirt22/2 BMDMs showed an induction of
the transcripts of pro-inflammatory cytokines, including Il1b,
Tnfa, Il6, and Mcp-1 (Figure 6A–B), and the down-regulation of
anti-inflammatory genes, like the Il4 receptor (Il4r) and Il10
(Figure 6C), highlighting a pro-inflammatory state in Sirt22/2
BMDMs in basal conditions.
In response to different stimuli, macrophages may undergo
classical M1 or alternative M2 polarization. The M1 phenotype is
characterized by the expression of high levels of pro-inflammatory
cytokines, while M2 macrophages are considered to have
immunosuppressive functions [22]. According to the observed
gene expression patterns (Figure 6B–C), BMDMs from Sirt2+/+
and Sirt22/2 mice possess different phenotypic profiles. We hence
treated BMDMs with either LPS or IL4 (Figure 6D–E), which
respectively are responsible for the induction of M1 or M2
polarization. LPS treatment induced the transcript levels of pro-
inflammatory cytokine genes in both genotypes, but the increase
was significantly more pronounced in the Sirt22/2 BMDMs
(Figure 6D). Alternatively, the IL4-mediated M1-to-M2 switch is
driven by the activation of the STAT6/GATA3 pathway [22].
IL4-stimulated Sirt22/2 BMDMs showed reduced Gata3 induc-
tion together with a lower expression of Arginase 1 (Arg1) and
Cd11c (Figure 6E), two well known M2 marker genes [23]. These
data demonstrate that SIRT2 deficiency also directly affects
macrophage polarization, mimicking a pro-inflammatory milieu.
The absence of SIRT2 expression triggers the
hyperacetylation of NF-kB in BMDMs
NF-kB activation plays a fundamental role in the transcriptional
regulation of inflammation-related genes and is associated with
several chronic inflammatory diseases [24]. Previous findings have
demonstrated a link between SIRT2 and NF-kB [4,5,6].
Hyperacetylation of the p65 subunit of NF-kB at Lys310, after
Sirt2 knockdown, has been linked to an increase in NF-kB-
dependent transcription, causing deleterious effects on inflamma-
tory diseases [4,5,6]. To gain further insight into the molecular
mechanisms underlying the effects of Sirt2 deletion on DSS-
induced colitis, we investigated whether the effects observed in
BMDMs were associated with alterations in the acetylation of NF-
kB. Sirt22/2BMDMs exhibited higher NF-kB acetylation under
both basal and LPS-treated conditions, while a slight increase in
acetylation was observed in Sirt2+/+ BMDMs after LPS stimula-
tion (Figure 7). Moreover, the basal phospho-IkBa levels in Sirt22/
2 BMDMs were similar to those of LPS-treated Sirt2+/+ BMDMs,
confirming the constitutive activation of NF-kB in Sirt22/2
BMDMs. Our data therefore supports that SIRT2 targets
Lys310 on the p65 subunit of NF-kB in BMDMs, resulting in
pro-inflammatory gene expression.
Discussion
In the present study, we identified a novel role for SIRT2 as a
potential suppressor of DSS-induced colitis in the mouse [13]. First
by interfering with intestinal barrier function, then stimulating
local inflammation and dysplasia, DSS-induced colitis resembles
the clinical progression of human UC, representing an important
model for the translation of mouse data to human disease
relevance [25]. Here we showed that SIRT2 deficiency led to a
more severe colitis compared to that seen in Sirt2+/+ control mice.
Although Sirt22/2 mice were indistinguishable from Sirt2+/+ mice,
with respect to body weight and intestinal morphology (Figures 1
and 2), upon a DSS challenge they developed more severe colitis
(Figures 3–5). Several reasons can be invoked to explain the absence
of a difference in the intestinal epithelium between Sirt2+/+ and
Sirt22/2 mice under basal conditions. First, Sirt2 belongs to the
family of Sirtuins, with 7 different members (Sirt1-7) that are
evolutionary conserved. The loss-of-function of one of the Sirtuins
could hence cause a compensatory increase in the function of other
family members. Second, intestinal epithelium undergoes a very fast
proliferation/differentiation/death cycle, due to the necessity for
continuous cell renewal. This fast regeneration of intestinal cells
implies the presence of several redundant checkpoints and makes it
unlikely that the mutation of a single gene, unless it is a master
regulator of proliferation (like b-catenin, p53, Notch, etc), exerts a
dominant effect under basal conditions.
However upon DSS challenge, together with increased accel-
eration in body weight loss and rectal bleeding, intestinal
permeability and histological score were exacerbated. Concor-
dantly, a more detailed histological analysis of the intestine showed
an increase in the extent of erosion/ulceration, and leukocytic
infiltration density with mural involvement (Figure 3). The
increased inflammation in Sirt22/2 mice was also highlighted by
the measurements of cytokine levels in the plasma and cytokine
mRNA expression in colon tissue. TNFa and IL1b levels in the
plasma and their transcript levels in the colon were increased in
Figure 1. Generation and characterization of the Sirt22/2 mouse model. (A) Schematic representation of the gene targeting strategy for
exons 5–7 of the Sirt2 gene. (B) Western blot analysis of SIRT2 expression in the liver, heart, and colon of Sirt2+/+ and Sirt22/2 mice. (C) Genotype and
sex distributions of newborn mice summarized from 162 colonies. (D) Body weight and body composition of Sirt2+/+ and Sirt22/2 mice.
doi:10.1371/journal.pone.0103573.g001
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Figure 2. Sirt22/2 and Sirt2+/+ mice colons are morphologically similar under normal conditions. (A and B) Representative images of
hematoxylin/eosin (A) and F4/80 staining (B) of the colon in Sirt2+/+ and Sirt22/2 mice. Number of F4/80+ cells are shown (right panel of B). n = 3/
group. Scale bar = 20 mm.
doi:10.1371/journal.pone.0103573.g002
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Sirt22/2 mice following DSS, while basal upregulation was limited
and only observed in colon tissue mRNA measurements
(Figure 5). In addition, the increased intestinal permeability in
Sirt22/2 mice upon DSS treatment was underscored by their
more pronounced reduction of colon TJ proteins, Ocln, Cldn1,
and Zo1, when compared to Sirt2+/+ animals.
Although germline Sirt22/2 mice represent a reliable genetic
model to study the pathophysiology of IBD, it is difficult to
determine the potential involvement of different tissues, including
intestine and immune cell compartment, in the development of
colitis. However, both morphological and gene expression analysis
in basal conditions defined the role of the intestinal tissue in the
development of colitis as secondary (Figure 2 and 5). Since the
Figure 3. Sirt22/2 mice are more sensitive to DSS-induced colitis compared to Sirt2+/+ animals. (A–D) Severity of DSS-induced colitis was
determined by body weight change (A), rectal bleeding scores (B), intestinal permeability (C), and histological scores (D) in Sirt2+/+ and Sirt22/2 mice.
n = 10/group. (E–H) Histological changes in the intestine of the DSS-treated Sirt2+/+ and Sirt22/2 mice. Representative images demonstrating the
extension of erosion/ulceration (arrows and dashed line indicate the extent of ulceration) (E), inflammation severity (arrows indicate leukocytic
infiltrate and follicular aggregates) (F), mural involvement (arrows indicate transmural infiltration) (G), and damage distribution (arrows indicate sites
of damage) (H). Corresponding histological scores are shown (lower panels). n = 10/group. Scale bar = 20 mm. Results are expressed as the mean 6
SEM. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0103573.g003
Figure 4. CD4+CD69+ T cells are increased in mesenteric lymph nodes from Sirt22/2 mice with DSS-induced colitis. (A) Representative
images of FACS analysis demonstrating TCRb+ cells (left), and their composition sorted by CD4 and CD69 staining (right). (B) The composition of
MLNs is compared between Sirt2+/+ and Sirt22/2 mice; TCRb+, CD4+, CD4+CD692, and CD4+CD69+ cells. n = 10/group. Results are expressed as the
mean 6 SEM. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0103573.g004
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Figure 5. Plasma cytokine levels and cytokine mRNA levels in the colon of Sirt22/2mice with DSS-induced colitis. (A–C) Measurements
of serum cytokine levels in Sirt2+/+ (+/+) and Sirt22/2 (2/2) mice after DSS-induced colitis; TNFa (A), IL1b (B), and IL6 (C). (D–E) Cytokine mRNA levels
in the colon of Sirt2+/+ and Sirt22/2 mice before and after DSS-induced colitis. Tnfa (D), Il1b (E), and Il6 (F). (G–H) mRNA levels of the genes related to
maintenance of intestinal permeability, Ocln (G), Cldn1 (H), Zo1(I) in Sirt2+/+ and Sirt22/2 mice with or without DSS treatment. n = 10/group (with DSS
treatment); n = 5/group (without DSS treatment). Results are expressed as the mean 6 SEM. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0103573.g005
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inflammatory cells of the gut are initially recruited from the bone
marrow compartment [26], bone marrow derived macrophages
(BMDMs) from Sirt2+/+ and Sirt22/2 mice were isolated and
examined ex vivo for functional differences. Notably, macrophages
have the unique ability to respond to environmental cues by taking
on one of two functional phenotypes designated as pro-inflamma-
tory M1 and anti-inflammatory M2 macrophages. Classically
activated M1 cells are implicated with initiating and sustaining
inflammation, while M2 cells are associated with the resolution of
chronic inflammation [27]. These two distinct phenotypes, M1
and M2, can be induced ex vivo by treating BMDMs with LPS or
IL4, respectively. Before macrophage activation, we found that
Sirt2 deficiency resulted in the basal induction in the transcript
levels of pro-inflammatory cytokine genes in BMDMs (Figure 6).
Moreover, upon LPS stimulation and M1 phenotype induction,
differences observed in Sirt22/2 mice-derived BMDMs under
basal conditions became accentuated (Figure 6). In addition,
Sirt22/2 BMDMs exhibited reduced basal mRNA expression
levels for the M2-associated anti-inflammatory cytokine Il10 and
the Il4 receptor [28,29]. IL4R activates the STAT6/GATA3
signaling cascade, which in turn controls transcription of genes
typical of M2 polarization (e.g. Arg1, Cd11c) [30]. Correspond-
ingly, after IL4 stimulation, Gata3 [22], Arg1, and CD11c [23]
mRNA expression is reduced in Sirt22/2 mice. In addition, the
hyperacetylation of the p65 subunit of NF-kB in Sirt22/2 BMDMs
may mechanistically contribute to the pro-inflammatory effect
exerted by Sirt2 deficiency. Consistent with previous studies [4,5],
hyperacetylation of NF-kB induces its activity, triggering inflam-
matory pathways. Moreover, it has been previously demonstrated
that the IL4/STAT6/GATA3 pathway negatively regulates NF-
kB-dependent gene expression [31]. Thus, the inhibition of the
IL4-dependent activation may unhinge an important repressive
mechanism used to counterbalance the inflammatory process.
These data hence demonstrate that Sirt2 deficiency predisposes to
and promotes inflammation, while also inactivating the classical
M2-associated anti-inflammatory pathways, as a primary cause for
the more severe development of colitis in these animals.
Our results demonstrate a potential role for SIRT2 as a
suppressor of colitis in the mouse. This also leads us to speculate
that the activation of SIRT2 may be a potential approach to treat
inflammatory bowel disease. Further investigations to identify
therapies targeting SIRT2 to improve inflammatory bowel disease
are hence warranted. Moreover, these findings also highlight the
novel role of SIRT2 in macrophage M1/M2 polarization, which
Figure 6. Increased mRNA levels of pro-inflammatory genes and decreased levels of anti-inflammatory genes in Sirt22/2 mouse-
derived BMDMs. (A) Sirt2 mRNA levels in Sirt2+/+ (+/+) and Sirt22/2 (2/2) mice. (B and C) mRNA levels of pro-inflammatory cytokine genes (Il1b,
Tnfa, Il6, Mcp1) (B) and anti-inflammatory genes (Il4r, Il10) (C) in BMDMs from Sirt2+/+ and Sirt22/2mice under basal conditions. n = 3/group. (D) mRNA
levels of pro-inflammatory genes in BMDMs from Sirt2+/+ and Sirt22/2 mice upon LPS treatment. (E) mRNA levels of Gata3, Arg1, and Cd11c in BMDMs
from Sirt2+/+ and Sirt22/2 mice upon IL4 treatment. Results are expressed as the mean 6 SEM. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0103573.g006
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could have far reaching implications for other inflammatory-
diseases.
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